nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.297	0.632	CbGbCtD
Arformoterol—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.102	0.217	CbGbCtD
Arformoterol—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0438	0.0931	CbGbCtD
Arformoterol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0268	0.0571	CbGbCtD
Arformoterol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Arformoterol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Arformoterol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Arformoterol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Arformoterol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Arformoterol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00041	0.000773	CcSEcCtD
Arformoterol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000408	0.000771	CcSEcCtD
Arformoterol—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000408	0.00077	CcSEcCtD
Arformoterol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00077	CcSEcCtD
Arformoterol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.000769	CcSEcCtD
Arformoterol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000408	0.000769	CcSEcCtD
Arformoterol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000407	0.000768	CcSEcCtD
Arformoterol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.000767	CcSEcCtD
Arformoterol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000406	0.000767	CcSEcCtD
Arformoterol—Pain—Vincristine—peripheral nervous system neoplasm	0.000406	0.000767	CcSEcCtD
Arformoterol—Rash—Melphalan—peripheral nervous system neoplasm	0.000405	0.000764	CcSEcCtD
Arformoterol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000405	0.000763	CcSEcCtD
Arformoterol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.000761	CcSEcCtD
Arformoterol—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000759	CcSEcCtD
Arformoterol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000401	0.000758	CcSEcCtD
Arformoterol—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000754	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000399	0.000753	CcSEcCtD
Arformoterol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000397	0.000749	CcSEcCtD
Arformoterol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000393	0.000741	CcSEcCtD
Arformoterol—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000741	CcSEcCtD
Arformoterol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000392	0.000739	CcSEcCtD
Arformoterol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.000739	CcSEcCtD
Arformoterol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000736	CcSEcCtD
Arformoterol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000736	CcSEcCtD
Arformoterol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00039	0.000735	CcSEcCtD
Arformoterol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000388	0.000733	CcSEcCtD
Arformoterol—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000733	CcSEcCtD
Arformoterol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000386	0.000729	CcSEcCtD
Arformoterol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.000729	CcSEcCtD
Arformoterol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000385	0.000726	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000383	0.000722	CcSEcCtD
Arformoterol—Infection—Etoposide—peripheral nervous system neoplasm	0.000382	0.000722	CcSEcCtD
Arformoterol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.00072	CcSEcCtD
Arformoterol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000381	0.00072	CcSEcCtD
Arformoterol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000716	CcSEcCtD
Arformoterol—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000716	CcSEcCtD
Arformoterol—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000713	CcSEcCtD
Arformoterol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000376	0.000709	CcSEcCtD
Arformoterol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000376	0.000709	CcSEcCtD
Arformoterol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000376	0.000709	CcSEcCtD
Arformoterol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000375	0.000707	CcSEcCtD
Arformoterol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000374	0.000706	CcSEcCtD
Arformoterol—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000703	CcSEcCtD
Arformoterol—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000698	CcSEcCtD
Arformoterol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000697	CcSEcCtD
Arformoterol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000689	CcSEcCtD
Arformoterol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.000687	CcSEcCtD
Arformoterol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.000686	CcSEcCtD
Arformoterol—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000685	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000363	0.000685	CcSEcCtD
Arformoterol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00036	0.000679	CcSEcCtD
Arformoterol—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000678	CcSEcCtD
Arformoterol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000678	CcSEcCtD
Arformoterol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.000668	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000665	CcSEcCtD
Arformoterol—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000663	CcSEcCtD
Arformoterol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000663	CcSEcCtD
Arformoterol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00035	0.000661	CcSEcCtD
Arformoterol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.000658	CcSEcCtD
Arformoterol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000653	CcSEcCtD
Arformoterol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000343	0.000648	CcSEcCtD
Arformoterol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000646	CcSEcCtD
Arformoterol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000342	0.000646	CcSEcCtD
Arformoterol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000645	CcSEcCtD
Arformoterol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000341	0.000643	CcSEcCtD
Arformoterol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000338	0.000638	CcSEcCtD
Arformoterol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000637	CcSEcCtD
Arformoterol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.000637	CcSEcCtD
Arformoterol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.000633	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000332	0.000627	CcSEcCtD
Arformoterol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000332	0.000627	CcSEcCtD
Arformoterol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000332	0.000626	CcSEcCtD
Arformoterol—Pain—Etoposide—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Arformoterol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Arformoterol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Arformoterol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000616	CcSEcCtD
Arformoterol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.000615	CcSEcCtD
Arformoterol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000325	0.000614	CcSEcCtD
Arformoterol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000609	CcSEcCtD
Arformoterol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000599	CcSEcCtD
Arformoterol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000317	0.000599	CcSEcCtD
Arformoterol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000598	CcSEcCtD
Arformoterol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000316	0.000596	CcSEcCtD
Arformoterol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000315	0.000594	CcSEcCtD
Arformoterol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000314	0.000593	CcSEcCtD
Arformoterol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.000592	CcSEcCtD
Arformoterol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000587	CcSEcCtD
Arformoterol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000586	CcSEcCtD
Arformoterol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000584	CcSEcCtD
Arformoterol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.000583	CcSEcCtD
Arformoterol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000306	0.000577	CcSEcCtD
Arformoterol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000575	CcSEcCtD
Arformoterol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Arformoterol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Arformoterol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Arformoterol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Arformoterol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000302	0.00057	CcSEcCtD
Arformoterol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000569	CcSEcCtD
Arformoterol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000569	CcSEcCtD
Arformoterol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000566	CcSEcCtD
Arformoterol—Rash—Vincristine—peripheral nervous system neoplasm	0.0003	0.000565	CcSEcCtD
Arformoterol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000299	0.000565	CcSEcCtD
Arformoterol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000565	CcSEcCtD
Arformoterol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000563	CcSEcCtD
Arformoterol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000563	CcSEcCtD
Arformoterol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000562	CcSEcCtD
Arformoterol—Headache—Vincristine—peripheral nervous system neoplasm	0.000298	0.000562	CcSEcCtD
Arformoterol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000554	CcSEcCtD
Arformoterol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.000553	CcSEcCtD
Arformoterol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000552	CcSEcCtD
Arformoterol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000543	CcSEcCtD
Arformoterol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000284	0.000535	CcSEcCtD
Arformoterol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000282	0.000533	CcSEcCtD
Arformoterol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000532	CcSEcCtD
Arformoterol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000532	CcSEcCtD
Arformoterol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000526	CcSEcCtD
Arformoterol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000524	CcSEcCtD
Arformoterol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000522	CcSEcCtD
Arformoterol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000276	0.000521	CcSEcCtD
Arformoterol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000521	CcSEcCtD
Arformoterol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00052	CcSEcCtD
Arformoterol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000518	CcSEcCtD
Arformoterol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000517	CcSEcCtD
Arformoterol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000272	0.000514	CcSEcCtD
Arformoterol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000512	CcSEcCtD
Arformoterol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000511	CcSEcCtD
Arformoterol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000504	CcSEcCtD
Arformoterol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000502	CcSEcCtD
Arformoterol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000265	0.0005	CcSEcCtD
Arformoterol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000499	CcSEcCtD
Arformoterol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000499	CcSEcCtD
Arformoterol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000263	0.000497	CcSEcCtD
Arformoterol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000492	CcSEcCtD
Arformoterol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000259	0.00049	CcSEcCtD
Arformoterol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000489	CcSEcCtD
Arformoterol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000485	CcSEcCtD
Arformoterol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000483	CcSEcCtD
Arformoterol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000254	0.00048	CcSEcCtD
Arformoterol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00048	CcSEcCtD
Arformoterol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000479	CcSEcCtD
Arformoterol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000478	CcSEcCtD
Arformoterol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000474	CcSEcCtD
Arformoterol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000471	CcSEcCtD
Arformoterol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000465	CcSEcCtD
Arformoterol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000463	CcSEcCtD
Arformoterol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000245	0.000462	CcSEcCtD
Arformoterol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000462	CcSEcCtD
Arformoterol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000458	CcSEcCtD
Arformoterol—Rash—Etoposide—peripheral nervous system neoplasm	0.000243	0.000458	CcSEcCtD
Arformoterol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000242	0.000458	CcSEcCtD
Arformoterol—Headache—Etoposide—peripheral nervous system neoplasm	0.000241	0.000455	CcSEcCtD
Arformoterol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000453	CcSEcCtD
Arformoterol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000452	CcSEcCtD
Arformoterol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00045	CcSEcCtD
Arformoterol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000448	CcSEcCtD
Arformoterol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000447	CcSEcCtD
Arformoterol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000444	CcSEcCtD
Arformoterol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000441	CcSEcCtD
Arformoterol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000435	CcSEcCtD
Arformoterol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000229	0.000431	CcSEcCtD
Arformoterol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000431	CcSEcCtD
Arformoterol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000428	CcSEcCtD
Arformoterol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000425	CcSEcCtD
Arformoterol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000425	CcSEcCtD
Arformoterol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000425	CcSEcCtD
Arformoterol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000424	CcSEcCtD
Arformoterol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000423	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000422	CcSEcCtD
Arformoterol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00042	CcSEcCtD
Arformoterol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000416	CcSEcCtD
Arformoterol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000415	CcSEcCtD
Arformoterol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000408	CcSEcCtD
Arformoterol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000407	CcSEcCtD
Arformoterol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000407	CcSEcCtD
Arformoterol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000405	CcSEcCtD
Arformoterol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000403	CcSEcCtD
Arformoterol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000399	CcSEcCtD
Arformoterol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000399	CcSEcCtD
Arformoterol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000397	CcSEcCtD
Arformoterol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000396	CcSEcCtD
Arformoterol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Arformoterol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Arformoterol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Arformoterol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000392	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00039	CcSEcCtD
Arformoterol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000388	CcSEcCtD
Arformoterol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000384	CcSEcCtD
Arformoterol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00038	CcSEcCtD
Arformoterol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000377	CcSEcCtD
Arformoterol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000377	CcSEcCtD
Arformoterol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000374	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000371	CcSEcCtD
Arformoterol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000369	CcSEcCtD
Arformoterol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000368	CcSEcCtD
Arformoterol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000368	CcSEcCtD
Arformoterol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000366	CcSEcCtD
Arformoterol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000363	CcSEcCtD
Arformoterol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000362	CcSEcCtD
Arformoterol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000358	CcSEcCtD
Arformoterol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000352	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000352	CcSEcCtD
Arformoterol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000351	CcSEcCtD
Arformoterol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000348	CcSEcCtD
Arformoterol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000348	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000343	CcSEcCtD
Arformoterol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000341	CcSEcCtD
Arformoterol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000336	CcSEcCtD
Arformoterol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000336	CcSEcCtD
Arformoterol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000335	CcSEcCtD
Arformoterol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000333	CcSEcCtD
Arformoterol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000332	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000325	CcSEcCtD
Arformoterol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000325	CcSEcCtD
Arformoterol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000323	CcSEcCtD
Arformoterol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Arformoterol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Arformoterol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Arformoterol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Arformoterol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00031	CcSEcCtD
Arformoterol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000308	CcSEcCtD
Arformoterol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000159	0.0003	CcSEcCtD
Arformoterol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000299	CcSEcCtD
Arformoterol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000298	CcSEcCtD
Arformoterol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000298	CcSEcCtD
Arformoterol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000292	CcSEcCtD
Arformoterol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000288	CcSEcCtD
Arformoterol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000279	CcSEcCtD
Arformoterol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000278	CcSEcCtD
Arformoterol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00027	CcSEcCtD
Arformoterol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000269	CcSEcCtD
Arformoterol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000267	CcSEcCtD
Arformoterol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000259	CcSEcCtD
Arformoterol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000258	CcSEcCtD
Arformoterol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000257	CcSEcCtD
Arformoterol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000256	CcSEcCtD
Arformoterol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000255	CcSEcCtD
Arformoterol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000249	CcSEcCtD
Arformoterol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000242	CcSEcCtD
Arformoterol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00024	CcSEcCtD
Arformoterol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000238	CcSEcCtD
Arformoterol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000237	CcSEcCtD
Arformoterol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000236	CcSEcCtD
Arformoterol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000224	CcSEcCtD
